Phase I study of the humanized epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with ECX (epirubicin, cisplatin and capecitabine) as first line treatment for advanced oesophagogastric (OG) adenocarcinoma
2005 ◽
Vol 23
(16_suppl)
◽
pp. 4028-4028
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 3512-3512
◽
2005 ◽
Vol 23
(16_suppl)
◽
pp. 3535-3535
◽
2014 ◽
Vol 10
(7)
◽
pp. 155
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 3512-3512
◽
2011 ◽
Vol 23
◽
pp. S3-S9
◽